Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Hankang Capital

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$54M
Portfolio companies 3
Lead investments 0
Key employees Soon
Stages of investment
Late Stage Venture

Areas of investment

  • Therapeutics
  • Pharmaceutical
  • Health Care
  • Biotechnology
  • Biopharma

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Hankang Capital:
Typical Co-investors
Hankang Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Hankang Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Clean Pacific Ventures California, San Francisco, United States
Dainippon Sumitomo Pharma Japan, Osaka, Osaka Prefecture
Diehl Ventures Bayern, Germany, Nuremberg
eCatalogs California, Los Angeles, United States
Foresight 4 VCT plc -
Security Pacific National Bank California, Los Angeles, United States
WFD Ventures New York, New York, United States
Wolverine Trading Chicago, Illinois, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

China Immunotech

Biopharma
Biotechnology
Health Care
Medical
Pharmaceutical
18 Jul 2022 Changping, Beijing, China

HanBio Therapeutics

Biotechnology
Therapeutics
$40M28 Jan 2022 Shanghai, Shanghai, China

Abbisko Therapeutics

Health Care
Pharmaceutical
Therapeutics
$123M07 Jan 2021 China, Shanghai

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Hankang Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: